SZLMY Financial Statements & Analysis
Complete financial statements for SZLMY including income statement, balance sheet, and cash flow statement. Analyze SZLMY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
23.3% ↑
Net Income
1.4% ↑
Gross Margin
1.8% ↑
Operating Margin
-17.4% ↓
Balance Sheet
Current Ratio
181.0% ↑
Debt to Equity
60.9% ↓
Asset Turnover
19.3% ↑
Cash Flow
Operating Cash Flow
1224.2% ↑
Net Cash Flow
201.8% ↑
Free Cash Flow
4151.6% ↑
Cash Flow to Debt
775.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 14.43B | 17.80B | 23.3% | |
| Gross Profit | 14.43B | 18.12B | 25.6% | |
| Operating Income | 1.64B | 1.67B | 1.9% | |
| Net Income | 1.21B | 1.23B | 1.4% | |
| EPS | 2.12 | 2.10 | 0.9% | |
| EBITDA | 2.13B | 2.00B | 5.9% | |
| Gross Margin | 100.00% | 101.80% | 1.8% | |
| Operating Margin | 11.34% | 9.37% | 17.4% | |
| Net Income Margin | 8.41% | 6.92% | 17.8% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 17.80B | 14.43B | 13.61B | — | — |
| Gross Profit | 18.12B | 14.43B | 13.93B | — | — |
| Operating Income | 1.67B | 1.64B | 1.34B | — | — |
| Net Income | 1.23B | 1.21B | 1.08B | — | — |
| EPS | 2.10 | 2.12 | 1.86 | — | — |
| EBITDA | 2.00B | 2.13B | 1.80B | — | — |
| Gross Margin | 101.80% | 100.00% | 102.35% | — | — |
| Operating Margin | 9.37% | 11.34% | 9.83% | — | — |
| Net Income Margin | 6.92% | 8.41% | 7.96% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into SZLMY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics